Anderson C L, Abraham G N
J Immunol. 1980 Dec;125(6):2735-41.
Since the U937 cell line expresses many characteristics of normal human monocytes and macrophages, we studied in detail its receptors for IgG by measuring direct binding and inhibition of binding of 16 radioiodinated human myeloma proteins representative of the 4 subclasses. As with normal monocytes, IgG1 and IgG3 bound most efficiently (17.3 and 15.7% bound), IgG4 less readily (7.1% bound), and IgG2 least readily (0.6% bound). Scatchard plots of IgG1 binding showed approximately 18,000 binding sites/cell with Ka approximately 10(8) liter/mol. IgG1 binding was inhibited equally well by IgG1 and IgG3 (50% inhibition with 0.26 +/- 0.03 and 0.26 +/- 0.09 microgram, respectively). IgG4 inhibited less readily (0.68 +/- 0.12 microgram). Three IgG2 proteins were not inhibitory (115 +/- 59) but one IgG2 myeloma inhibited well (0.89 +/- 0.47). IgG Fc fragments inhibited IgG1 binding 1000-fold more efficiently than Fab fragments, IgM, and IgA. Reciprocal inhibition experiments gave no indication of multiple receptor sites of differing specificities. In situ, the IgG1 receptor was resistant to proteases. The data suggest that the U937 Fc receptor may be a useful model of human macrophage structure and function.
由于U937细胞系表现出许多正常人单核细胞和巨噬细胞的特征,我们通过测量16种代表4个亚类的放射性碘化人骨髓瘤蛋白的直接结合和结合抑制,详细研究了其IgG受体。与正常单核细胞一样,IgG1和IgG3结合最有效(结合率分别为17.3%和15.7%),IgG4结合较不明显(结合率7.1%),而IgG2结合最不明显(结合率0.6%)。IgG1结合的Scatchard图显示每个细胞约有18,000个结合位点,Ka约为10(8)升/摩尔。IgG1和IgG3对IgG1结合的抑制效果相同(分别用0.26±0.03和0.26±0.09微克时抑制50%)。IgG4抑制作用较弱(0.68±0.12微克)。三种IgG2蛋白无抑制作用(115±59),但一种IgG2骨髓瘤蛋白抑制效果良好(0.89±0.47)。IgG Fc片段对IgG1结合的抑制效率比Fab片段、IgM和IgA高1000倍。相互抑制实验未显示存在不同特异性的多个受体位点。在原位,IgG1受体对蛋白酶有抗性。这些数据表明,U937 Fc受体可能是人类巨噬细胞结构和功能的有用模型。